Modified xylanases exhibiting improved expression
A modified Family 11 xylanase enzyme comprising a sequence that introduces a functional consensus glycosylation site is provided. Non-limiting examples of introduced glycosylation sites include mutation of the amino acid at position 34, 131, 180, 182, or a combination thereof, to an asparagine. The indicated amino acid position in the Family 11 xylanase is determined from sequence alignment of the xylanase of interest with that of a Trichoderma reesei xylanase II amino acid sequence. The introduced consensus glycosylation site facilitates increased expression efficiency of the modified xylanase when compared to the expression efficiency of a corresponding xylanase from which the modified xylanase was derived, using similar host strains and growth conditions.
1. An isolated, modified Family 11 xylanase comprising, a functional consensus N-glycosylation site that is not found in a parental Family 11 xylanase from which the modified Family 11 xylanase is obtained, the modified Family 11 xylanase comprising nonnative asparagine at one or more of position 34 (X34N), position 131 (X131N), position 180 (X18ON), position 182 (X182N), the position number determined from sequence alignment of the modified Family 11 xylanase with the amino acid sequence of SEQ ID NO:1,
wherein the modified Family 11 xylanase, when expressed from a genetic construct comprising a promoter and a secretion signal in a Trichoderma host strain, exhibits an increase in expression efficiency of at least 40% when compared to the expression efficiency of said parental Family 11 xylanase expressed in a genetic construct with the same promoter and secretion signal.
2. The modified Family 11 xylanase of claim 1 , comprising X131N.
3. The modified Family 11 xylanase of claim 1 , further comprising amino acid substitutions comprising nonnative threonine at one or more of position 36 (X34N-S36T), position 182 (X180N-S182T) and position 184 (X182N-S184T).
4. The modified Family 11 xylanase of claim 1 , wherein the Family 11 xylanase is a Trichoderma xylanase.
5. The modified Family 11 xylanase of claim 4 , wherein the xylanase is Trichoderma reesei xylanase I or xylanase II.
6. The modified Family 11 xylanase of claim 1 , wherein the modified Family 11 xylanase is the S. lividans xylanase C of SEQ ID NO: 39 having an amino acid substitution of T128N.
7. The modified Family 11 xylanase of claim 1 , wherein the modified Family 11 xylanase is the Trichoderma reesei xylanase I of SEQ ID NO: 2 having an amino acid substitution of T118N.
8. An isolated, modified Trichoderma reesei Family 11 xylanase comprising a functional consensus N glycosylation site that is not found in the Trichoderma reesei Family 11 xylanase from which the modified Family 11 xylanase is obtained, said modified Family 11 xylanase having the amino acid sequence of SEQ ID NO:1 with amino acid substitutions selected from the group consisting of:
N10H, Y27M, N29L, S75A, L105H, Q125A, I129E, T131N, H144R, N157D, Q161R, Q162H, and T165R;
N10H, Y27M, N29L, S75A, L105H, Q125A, I129E, T131N, Y135R, H144R, N157D, Q161R, Q162H and T165R;
N10H, Y27M, N29L, S75A, L105H, Q125A, I129E, H144R, N157D, Q161R, Q162H, T165R and F180N;
N10H, Y27M, N29L, S75A, L105H, Q125A, I129E, H144R, N157D, Q161R, Q162H, T165R, F180N and S182T;
N10H, Y27M, N29L, S75A, L105H, Q125A, I129E, H144R, N157D, Q161R, Q162H, T165R and S182N;
N10H, Y27M, N29L, S75A, L105H, Q125A, I129E, H144R, N157D, Q161R, Q162H, T165R, S182N and S184T;
N10H, Y27M, N29L, Q34N, S75A, L105H, Q125A, I129E, H144R, N157D, Q161R, Q162H and T165R; and
N10H, Y27M, N29L, Q34N, S36T, S75A, L105H, Q125A, I129E, H144R, N157D, Q161R, Q162H and T165R.
9. A method of processing food or feed comprising, treating the food or feed with the modified Family 11 xylanase of any one of claims 1 - 8 .
10. A method of paper pulp manufacturing comprising treating the pulp with the modified Family 11 xylanase of any one of claims 1 - 8 .